Table 2.
Anti-proliferative activities of isothiocyanates against two types of human cancer cell lines, Panc1 (pancreatic cancer) and HGC27 (gastric cancer), measured by MTS assays.
| Compound | IC50 (μM) | |
|---|---|---|
| Panc1 | HGC27 | |
| PEITC | 10.80 ± 0.25 | 2.95 ± 0.41 |
| 1 | 15.80 ± 1.06 | 8.79 ± 0.72 |
| 2 | 10.87 ± 0.47 | 1.49 ± 0.06 |
| 3 | 14.24 ± 0.50 | 2.73 ± 0.29 |
| 4 | 6.12 ± 0.13 | 3.44 ± 0.23 |
| 5 | 8.05 ± 0.36 | 2.67 ± 0.37 |
| 6 | 4.55 ± 0.32 | 1.09 ± 0.07 |
| 7 | 2.04 ± 0.21 | 0.46 ± 0.02 |
| 8 | 5.78 ± 0.56 | 0.74 ± 0.01 |
| 9 | 3.52 ± 0.11 | 0.84 ± 0.06 |
| 10 | 2.68 ± 0.21 | 0.93 ± 0.41 |
| 11 | 5.08 ± 0.02 | 1.47 ± 0.10 |
| 12 | 8.92 ± 0.43 | 0.72 ± 0.21 |
| 13 | 5.65 ± 0.16 | 0.99 ± 0.15 |
| 14 | 2.25 ± 0.21 | 0.62 ± 0.04 |
| 15 | 3.76 ± 0.05 | 1.68 ± 0.00 |
| 16 | 6.24 ± 0.13 | 2.37 ± 0.43 |
| 17 | 4.70 ± 0.27 | 0.77 ± 0.18 |
| 18 | 2.78 ± 0.72 | 0.34 ± 0.00 |
| 19 | 2.14 ± 0.79 | 0.72 ± 0.08 |
| 20 | 4.06 ± 0.57 | 0.82 ± 0.06 |